Pancreatic Adenocarcinoma Metastatic Active Not Recruiting Phase 1 Trials for Metformin (DB00331)

Also known as: Metastatic Pancreatic Adenocarcinoma / Pancreatic carcinoma metastatic

IndicationStatusPhase
DBCOND0060224 (Pancreatic Adenocarcinoma Metastatic)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02336087Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by SurgeryTreatment